Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPulmonary Disease Physician in Baltimore, MD
NPI: 1003857384Primary Practice Location
JOHNS HOPKINS BAYVIEW MEDICAL CENTER
4940 Eastern Ave, Baltimore, MD
Primary Employer
Jhu - Neurology
hopkinsmedicine.org
HQ Phone
Get M.D. Christopher's Phone Numberphone_androidMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MD State Medical License
1990 - 2026
NC State Medical License
2020 - 2022
TX State Medical License
1987 - 1991
American Board of Internal Medicine
Internal Medicine
American Board of Psychiatry and Neurology
Neurology
University of Virginia Medical Center
Residency • Neurology
1987 - 1990
National University of Ireland, Galway Faculty of Medicine
Medical School
Until 1983
Baylor College Of Medicine
bcm.edu
Residency • Internal Medicine
1984 - 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 145 | 157 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 84 | 107 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 94 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 21 | 21 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 17 | 17 |
In memoriam: Richard P. Allen.
Authors: Christopher J. Earley
Publication Date: 2021-01
Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy.
Authors: Lynn Marie Trotti, David Rye
Publication Date: 2020-01-07
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.
Authors: Nathan Silver, Richard Allen, Julia Senerth, Christopher Earley
Publication Date: 2010-07-31
Lead Sponsor: Johns Hopkins University
Collaborators: National Institutes of Health (NIH)
Lead Sponsor: American Regent, Inc.
Collaborators: National Institute on Aging (NIA)
Intervention / Treatment: DRUG: Placebo, DRUG: Ferric Carboxymaltose (FCM)
Lead Sponsor: American Regent, Inc.
Intervention / Treatment: DRUG: Placebo (Normal Saline), DRUG: Injectafer® (Ferric Carboxymaltose - FCM)
